This year, the Albert Lasker Basic Medical Research Award will be shared by Richard Scheller and Thomas Sü dhof for their elucidation of the molecular mechanisms underlying neurotransmitter release. Their discoveries provided insight into the molecular basis of synaptic transmission and enhanced our understanding of how synaptic dysfunction may cause neuropsychiatric disorders.
Hitting a fastball, writing a symphony, or simply pulling fingers off a hot plate in a timely fashion all depend on neuron-toneuron and neuron-to-muscle communication that happens simultaneously at millions of synapses throughout the central and peripheral nervous systems. Indeed, chemical synaptic transmission has been conserved through the millions of years that it has taken the brains of primitive organisms such as flies and worms to evolve into the 3-pound organ sitting in our heads. The seminal work of pioneers including Otto Loewi and Sir Henry Dale (who shared the 1936 Nobel Prize in Physiology or Medicine) and Sir John Eccles (1963 Nobel Prize in Physiology or Medicine) established that presynaptic neurons release chemical messengers (neurotransmitters) that, depending on their identity, can either excite or inhibit postsynaptic targets, including muscles and other neurons. Working at the neuromuscular junction, Sir Bernard Katz (1970 Nobel Prize in Physiology or Medicine) made the critical observation that neurotransmitters are released in preassembled multimolecular packages termed ''quanta'' and that the very rapid action potential-evoked release of neurotransmitter quanta is triggered by calcium that enters presynaptic nerve terminals when an action potential opens voltagegated calcium channels. The quantal nature of chemical synaptic transmission was confirmed by electron microscopic images showing that presynaptic terminals are full of tens to hundreds of small uniform vesicles, the perfect containers for neurotransmitter quanta ( Figure 1A ).
These pioneering studies established that the presynaptic release machinery evolved to achieve the critical goal of very rapid triggering of neurotransmitter release at the right place (synapses) and at precisely the right time, when an action potential invades the presynaptic terminal. For many decades, however, the molecular machinery responsible for the exquisite calcium-dependent control of neurotransmitter release was unknown. Richard Scheller and Thomas Sü dhof receive this year's Basic Medical Research Award from the Albert Lasker Foundation for their brilliant elucidation of the key molecular machinery and regulatory mechanisms that underlie the rapid release of neurotransmitter. Their efforts led to an exquisitely detailed picture of the molecular interactions underlying presynaptic vesicle fusion with the presynaptic plasma membrane and revealed how this fusion event is tightly regulated, such that it is rapidly triggered by the influx of calcium during an action potential. Their elucidation of this fundamental property of all chemical synapses in primitive and advanced nervous systems alike opened the flood gates to a detailed molecular understanding of synaptic function. As a consequence, we have gained insight into the molecular underpinnings of the brain's amazing functions and the molecular pathophysiology of devastating neuropsychiatric disorders. The first synaptic vesicle protein to be isolated and cloned was synaptophysin, but as luck would have it, despite major efforts, the function of synpatophysin remains enigmatic. Within a year of each other, Scheller, using cholinergic vesicles from the electric organ of Torpedo, and Sü dhof and Jahn, using rat brain presynaptic vesicles, cloned the synaptic vesicle membrane protein synaptobrevin/VAMP-1 (Trimble et al., 1988; Sü dhof et al., 1989) . This was fortuitous because synaptobrevin/VAMP-1 turned out to be a ''v-SNARE,'' one of the three critical components of SNARE protein-mediated membrane fusion, a topic for which the 2002 Lasker Basic Medical Research Award was given to James Rothman and Randy Schekman. Indeed, the work of Rothman and Schekman on the budding and NSF/SNAP-dependent fusion of membrane vesicles in reconstitution systems and yeast, respectively, was conducted roughly at the same time as the efforts of Scheller and Sü dhof. These complementary approaches interfaced beautifully such that the results from Scheller/Sü dhof informed the work of Rothman/Schekman and vice versa.
Rapid Progress
Morphological examination of presynaptic terminals and biophysical studies of synaptic transmission in preparations such as the squid giant synapse made it clear that some presynaptic vesicles were docked at the membrane of specialized sites called active zones, the sites at which neurotransmitter release occurs, and that the molecular machinery mediating vesicle fusion is likely preassembled to allow the very rapid calcium-dependent triggering of neurotransmitter release. Thus, to understand neurotransmitter release mechanisms required defining the protein-protein interactions that mediate these functions. By examining a protein complex immunoprecipitated with an antibody to another synaptic vesicle protein that Sü dhof had cloned (Perin et al., 1990) , Scheller isolated syntaxin, found that it was localized to the active zone plasma membrane, and proposed that it was involved in synaptic vesicle docking and/or fusion (Bennett et al., 1992) .
Independently, Rothman and colleagues used bovine brain to search for proteins that were ''receptors'' for NSF and SNAPS, essential components of the intracellular membrane fusion machinery that he had characterized, and identified syntaxin and synaptobrevin/ VAMP as well as SNAP-25 as ''SNAREs'' (an abbreviation for SNAP receptors).
(''SNAP-25'' is a different protein than the ''SNAP'' that partners with NSF.) Importantly, Rothman found that SNAREs form a complex, leading to a collaboration in which Scheller and Rothman demonstrated that in the absence of NSF and SNAP, the complex of these three proteins is dissociated by NSF, which acts as an ATPase (Sö llner et al., 1993) . Scheller amplified these results by demonstrating a direct interaction of syntaxin with synaptobrevin/VAMP and that multiple syntaxins are expressed in brain and contribute to the specificity of membrane fusion in distinct intracellular compartments Scales et al., 2000) . Moreover, in an influential review, Scheller was the first to clearly describe the evolutionary conservation of membrane trafficking fusion machinery in all eukaryotic membrane traffic by comparing presynaptic vesicle fusion mechanisms to the results emerging from yeast and C. elegans genetics .
At the same time, Sü dhof was making additional seminal discoveries about the proteins mediating and regulating presynaptic vesicle fusion. Cesare Montecucco and Reinhard Jahn had shown, partly in collaboration with Sü dhof, that the same three proteins which were identified as ''SNAREs'' by Rothman (synaptobrevin/ VAMP, syntaxin, and SNAP-25) were the targets of botulinum toxins and tetanus toxin, proteases that dramatically inhibit neurotransmitter release. These findings provided compelling evidence that these SNARE proteins were indeed part of the core machinery mediating presynaptic vesicle fusion. Moreover, Sü dhof discovered Munc18, which he isolated in a tight complex with syntaxin, and proposed that Munc18 is an integral component of the membrane fusion complex together with the three SNARE proteins (Hata et al., 1993) . This hypothesis was borne out in subsequent studies demonstrating that Munc18 was not only required for all neurotransmitter release but that it was a founding member of what is now called the SM protein family for ''Sec1/ Munc18-like proteins,'' which are essential for all SNARE-dependent fusion reactions.
Synaptotagmins: CalciumDependent Triggers for Release Although neurotransmitter release uses a molecular machinery that is shared with many other types of intracellular membrane fusion, it is unique in its exquisite control by calcium. How is it possible for a rise in calcium to trigger vesicle fusion in a few hundred microseconds? In an elegant series of experiments over the course of two decades, Sü dhof led the way in unequivocally demonstrating that synaptotagmins are the proteins that bind calcium and trigger the fusion of presynaptic vesicles as well as other calcium-dependent secretory organelles. The first synaptotagmin was isolated as a synaptic vesicle antigen termed protein p65 because its function was unknown. In 1990, Sü dhof, in collaboration with Reinhard Jahn, isolated the cDNA for p65 and deduced that it contained a single N-terminal transmembrane region, presumably important for tethering synaptotagmin-1 (the now standard name for p65) to presynaptic vesicles and two C-terminal calcium-binding C 2 domains (Perin et al., 1990 ). These C 2 domains resembled sequences in protein kinase C that had no known function, although protein kinase C was thought to bind phospholipids and be activated by calcium. Sü dhof proceeded to demonstrate that the C 2 domains in synaptotagmin-1 directly bind calcium as well as acidic phospholipids and later demonstrated the same for the protein kinase C C 2 domains, thus establishing C 2 domains as general calcium-binding domains. He then had the insight that synaptotagmin-1 might function as a calcium-activated bridge that drives final fusion pore opening by tightly connecting docked presynaptic vesicles (via its N-terminal domain) to phospholipids in the active zone plasma membrane (via its calcium-activated C 2 domains) ( Figure 1B ). In the decade following the cloning of synaptotagmin-1, Sü dhof, in collaboration with structural biologists such as Jose Rizo and electrophysiologists such as Chuck Stevens, used an impressive variety of biochemical and structural techniques to demonstrate that the C 2 domains of synaptotagmin-1 bind calcium cooperatively, form a ternary complex with phospholipid bilayers, and importantly, also bind SNARE proteins in a calcium-dependent fashion.
While the biochemical and structural properties of synaptotagmin-1 made it a very attractive candidate to be the calcium trigger for neurotransmitter release, both Sü dhof and Scheller appreciated that the proof would come from direct assays of release. In an early experiment, Scheller found that injecting PC12 cells with an antibody against synaptotagmin-1 or a soluble C 2 -domain-containing peptide fragment inhibited a measure of K + / calcium-mediated regulated secretion . Sü dhof took a comprehensive genetic approach to elucidate the function of synaptotagmin. He first demonstrated that knocking out synaptotagmin-1 was lethal and in cultured neurons caused a dramatic impairment in synaptic transmission, wiping out fast, synchronous calcium-dependent neurotransmitter release (Geppert et al., 1994) . In an elegant demonstration of the power of mouse genetics, he then used the knowledge gained from his biochemical and structural work to generate a knockin mouse in which wild-type synaptotagmin-1 was replaced by synaptotagmin-1 containing a single point mutation, which causes a 2-fold decrease in overall calcium affinity without inducing structural or conformational changes (Ferná ndez-Chacó n et al., 2001). Remarkably, electrophysiological studies of synaptic transmission in cultured neurons taken from these mice revealed a 2-fold decrease in the calcium sensitivity of neurotransmitter release.
It is now well accepted that synaptotagmins are the key calcium-dependent triggers for fast, synchronous neurotransmitter release as well as playing a key role in calcium-dependent exocytosis from endocrine cells and many other nonneuronal cells. Sü dhof's genetic experiments also established that synaptotagmins act by binding to both SNAREs and to phospholipids in a calcium-regulated manner. Synaptotagmins and their interactions are evolutionarily conserved with multiple isoforms found in vertebrates and invertebrates in which they perform similar functions. In mammals, there are 16 synaptotagmin isoforms, 8 of which bind calcium with varying affinities. Synaptotagmin-1, -2 and -9 appear to be the most important in triggering neurotransmitter release at rodent forebrain synapses, albeit with different kinetics. The roles of the other synaptotagmins are an active area of research with one possibility being that some function in triggering slower, asynchronous forms of exocytosis and neurotransmitter release.
Synaptotagmin, however, does not act alone in the calcium control of membrane fusion. Sü dhof identified complexin based on its strong binding to the SNARE complex (hence the name; McMahon et al., 1995) . Surprisingly, analysis of complexin-deficient synapses revealed that it is not essential for fusion itself but for the calcium-mediated control of fusion by synaptotagmin (Maximov et al., 2009 ). It appears that all forms of synaptotagmin-dependent exocytosis examined thus far also require complexin. Electrophysiological studies of synaptic transmission following molecular manipulations of complexin and cell fusion assays reveal that it has two important functions. It ''clamps'' the fusion reaction by preventing complete SNARE complex assembly until synaptotagmin binds calcium and simultaneously it is required for ''activating'' SNARE complexes before the final fusion step triggered by the calcium-dependent activation of synaptotagmin. One attractive model is that complexin binds strongly to partially assembled SNARE complexes at docked synaptic vesicles, thereby activating these complexes, and that upon binding calcium synaptotagmin displaces the complexin clamp, allowing fusion pore opening.
Additional Progress
Given the fundamental importance of neurotransmitter release for brain function, of course, it is not surprising that other investigators have made essential contributions to this topic. Among others, the work of Reinhard Jahn, Axel Brunger, and Jose Rizo has led over the last decade to an exquisitely detailed molecular model of how SNARE complex formation via the ''zippering'' of parallel four-helix bundles in the individual SNARE proteins (one bundle in syntaxin and synaptobrevin, two in SNAP-25) leads to membrane fusion. Biophysical and imaging studies of neurotransmitter release in preparations such as cultured neurons and the calyx of Held have revealed the recycling of presynaptic vesicles after they fuse to the plasma membrane and quantitative estimates of the exact calcium concentrations within nerve terminals that trigger release. In addition, the molecular composition of active zones, the specialized sites within presynaptic terminals at which vesicles dock and fuse, have been defined and the detailed functions and interactions of specific protein components are being elucidated. Of note is the answer to an old question raised by the work of Bernard Katz: how is calcium influx targeted to the presynaptic active zone of a nerve terminal? A protein complex centered on a multidomain protein called RIM has been identified that genetic deletion studies suggest simultaneously tethers calcium channels to the active zone, docks synaptic vesicles at the active zone, and recruits the critical priming factor Munc13 to the active zone (Kaeser et al., 2011) . Thus, we now not only have a molecular framework that accounts for synaptic vesicle fusion and its control by calcium, but also an understanding of how calcium is channeled to the site of vesicle fusion. All of these advances are in large part a consequence of the pioneering work of Scheller and Sü dhof, who led the way in successfully dissecting the molecular machinery of neurotransmitter release.
Concluding Remarks
At a time when funding is tight, and there is increasing pressure to perform ''applied'' or ''translational'' research on disease models, the Lasker Foundation is to be congratulated for recognizing the critical importance of pure basic research on a fundamental biological topic. Scheller and Sü dhof did not set out to understand a disease but were fascinated by the molecular basis of neurotransmitter release. They were convinced that their efforts would provide insight into membrane fusion in general as well as other key aspects of synaptic function. Furthermore, they knew that doing the very best basic science would lead to advances that benefit human health. Indeed, work on the molecular mechanisms of neurotransmitter release has provided insight into the pathophysiology of neurodegenerative diseases such as Parkinson's and led to the identification of many additional synaptic proteins that are strongly implicated in the pathophysiology of complex brain disorders, such as the synaptic cell adhesion proteins neurexins and neuroligins.
Two lessons, which funding agencies might note, are that arguably the best predictor of future success is past success and that it is often best to fund people, not detailed projects. Indeed, Scheller has gone on to huge success as the leader of Genentech's research engine and Sü dhof continues to make countless discoveries aiding our understanding of synaptic function. In today's world, these investigators would find it very difficult to generate the grant support necessary to take the approaches that garnered them the Lasker. Thus, their home institutions, the University of Texas Southwestern Medical Center and Stanford University as well as the Howard Hughes Medical Institute, which supported their efforts, are also to be congratulated for placing bets on promising new investigators who were willing to take the risk of tackling a new research topic. We should all join in celebrating this year's Lasker Basic Medical Research Award winners who now deservedly join the luminaries who have shed light on the mystery that is synaptic transmission.
